04 March 2022 | Influencers
Aims to assist healthcare professionals to navigate clinical diagnosis and early medical therapy to mark "Endometriosis Awareness Month"
Photo Credit: Freepik
In the lead-up to Endometriosis Awareness Month, Bayer, together with clinical experts across the region, has unveiled a new consensus guideline, “Clinical Diagnosis and Early Medical Management for Endometriosis: Consensus for Asia”. The first-of-its-kind consensus aims to help healthcare professionals navigate clinical diagnosis and early medical therapy for the treatment of endometriosis to deliver the best patient outcomes.
The consensus aligns with the latest 2022 guidelines published by European Society of Human Reproduction and Embryology (ESHRE), which details the best practices of caring for women with endometriosis. Both works emphasize the importance of non-invasive procedures in early diagnosis and treatment to allow for patient-centered care. For instance, symptom recognition is recommended before utilising laparoscopy for diagnosis, and medical treatments are recommended for the management of pain post-surgery.
“With up to 10% of women of reproductive age worldwide affected by endometriosis, it continues to pose a serious burden globally and in our region. Asia Consensus guidelines allow us to help healthcare professionals tackle the endometriosis burden by improving diagnosis and treatment standards of the condition in Asia, enabling them to create the best outcomes for their patients,” said Catherine Donovan, Vice President Head of Medical Affairs Asia-Pacific, Bayer Pharmaceuticals Asia-Pacific.
Bayer spearheaded the #DontLiveWithPain campaign to address the information gap associated with this condition by encouraging women to seek early treatment.
Themed “Don’t Live With Pain. Period.”, the #DontLiveWithPain campaign is an initiative championed by Bayer to create awareness, educate and help modern-day women understand what endometriosis is, and how they can manage the condition.
Using Consensus Guidelines experts evaluate evidence, international guidelines and consensus reports around the clinical diagnosis and early medical management of endometriosis in Asia.